| LONDON, United Kingdom — March 17, 2026. LabGenius Therapeutics (“LabGenius”), a drug discovery company combining artificial intelligence (AI), high-throughput experimentation and machine-learning to discover next-generation therapeutic antibodies, today announced that a scientific poster will be presented at the AACR Annual Meeting 2026, being held April 17–22, 2026, at the San Diego Convention Center, California. The […] The post Press release |
LabGenius Therapeutics Announces Poster Presentation at the AACR Annual Meeting 2026 first appeared on LabGenius Therapeutics . |
